BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8252800)

  • 1. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
    Singh AK; Kasinath BS
    Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephritogenicity and immunocytochemical localization of the 70-kilodalton glycoprotein subunit (gp70) of Heymann antigen.
    Singh AK; Schwartz MM
    Clin Immunol Immunopathol; 1988 Jul; 48(1):61-77. PubMed ID: 3289803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
    Kerjaschki D; Miettinen A; Farquhar MG
    J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats.
    Kerjaschki D; Farquhar MG
    J Exp Med; 1983 Feb; 157(2):667-86. PubMed ID: 6337231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen.
    Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T
    Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of two forms of GP330. Their role in Heymann nephritis.
    Bachinsky DR; Zheng G; Niles JL; McLaughlin M; Abbate M; Andres G; Brown D; McCluskey RT
    Am J Pathol; 1993 Aug; 143(2):598-611. PubMed ID: 8342605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential localization of antibody to multiple regions of the glomerular capillary wall in passive Heymann nephritis.
    Rydel JJ; Schwartz MM; Singh AK
    Lab Invest; 1989 Apr; 60(4):492-8. PubMed ID: 2651800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of antibodies with human glomerular epithelial cells.
    Fukatsu A; Yuzawa Y; Olson L; Miller J; Milgrom M; Zamlauski-Tucker MJ; Van Liew JB; Campagnari A; Niesen N; Patel J
    Lab Invest; 1989 Oct; 61(4):389-403. PubMed ID: 2796288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of cytoplasmic tail-containing form of gp600/megalin in active Heymann nephritis.
    Oleinikov AV; Makker SP
    J Pathol; 2000 Oct; 192(2):251-6. PubMed ID: 11004703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
    Kerjaschki D; Neale TJ
    J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I.
    Makino H; Gibbons JT; Reddy MK; Kanwar YS
    J Clin Invest; 1986 Jan; 77(1):142-56. PubMed ID: 2935558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 400-kd protein in the brush borders of human kidney tubules that is similar to gp330, the nephritogenic antigen of rat Heymann nephritis.
    Kerjaschki D; Horvat R; Binder S; Susani M; Dekan G; Ojha PP; Hillemanns P; Ulrich W; Donini U
    Am J Pathol; 1987 Oct; 129(1):183-91. PubMed ID: 2444109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to basement membrane heparan sulfate proteoglycans bind to the laminae rarae of the glomerular basement membrane (GBM) and induce subepithelial GBM thickening.
    Miettinen A; Stow JL; Mentone S; Farquhar MG
    J Exp Med; 1986 May; 163(5):1064-84. PubMed ID: 2939168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparative polyacrylamide gel electrophoresis in the isolation of the nephritogenic proteins of passive Heymann nephritis.
    Miettinen A; Törnroth T; Vartio T
    APMIS; 1989 Jun; 97(6):479-89. PubMed ID: 2660856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
    Kerjaschki D
    Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
    Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA
    J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with monoclonal antibodies against brush border antigens in Heymann nephritis.
    Bhan AK; Schneeberger EE; Baird LG; Collins AB; Kamata K; Bradford D; Erikson ME; McCluskey RT
    Lab Invest; 1985 Oct; 53(4):421-32. PubMed ID: 3900581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.